Pharmaceutical

Disc wins orphan drug tag for rare blood cancer  

The humanised monoclonal antibody DISC-3405 is under investigation in a Phase I clinical trial, with data expected this year.

Feb 12, 2024 - 18:00
Disc wins orphan drug tag for rare blood cancer  
The humanised monoclonal antibody DISC-3405 is under investigation in a Phase I clinical trial, with data expected this year.
Read the original article

Tags:

Previous Article

Science and menopause under the spotlight during the Super Bowl

Next Article

First targeted alpha therapy wins FDA breakthrough device designation

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Can the government ask social media sites to take down Covid misinformation? SCOTUS will weigh in

Can the government ask social media sites to take down ...

Jan 30, 2024

Flu vaccine offering decent levels of protection this winter, new data show

Flu vaccine offering decent levels of protection this w...

Feb 29, 2024

SparingVision shares trial updates for rare eye disease gene therapies

SparingVision shares trial updates for rare eye disease...

Sep 15, 2023